Cencora Ventures is Cencora’s corporate venture capital arm, investing in companies advancing pharmaceuticals, healthcare products, life sciences and medication access. It is stage-agnostic with an emphasis on early to mid-stage venture rounds, has led or co-led Series A and Series B investments, and can reserve capital for follow-ons. The firm invests globally with a focus on the United States and Western Europe, typically writing $1M to $10M initial checks.